Radiotherapy

Five-fraction stereotactic body radiotherapy proved noninferior to conventional radiotherapy with regard to biochemical or clinical failure for men with localized prostate cancer, according to randomized phase 3 study results.

Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.

A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.

Inpatient management of people with cancer varied considerably based on their housing status, according to results of a cross-sectional study.

A generic version of a treatment for acromegaly is now available for adults in the U.S., according to an industry press release.

Adjuvant radiotherapy reduced risk for local recurrence for a decade among women with early breast cancer who underwent breast-conserving surgery, results of a randomized phase 3 trial showed.

Radiotherapy poses no significant risks for worsening disease in patients with systemic sclerosis, but entails “variable risk” for both acute and late toxicities, according to data published in The Journal of Rheumatology.

Radiotherapy and hematopoietic cell transplant increased the risk for keratinocyte carcinoma development in childhood cancer survivors, according to a study.

Dental extractions after radiation therapy to the head and neck should not be routinely performed due to considerable risk, according to results of a prospective cohort study.

Exposure of certain cardiac structures to radiation during treatment of surgically inoperable or unresectable non-small cell lung cancer was associated with increased arrhythmia risk, researchers reported.